0001209191-24-003544.txt : 20240220 0001209191-24-003544.hdr.sgml : 20240220 20240220164259 ACCESSION NUMBER: 0001209191-24-003544 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240215 FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burgess Justin CENTRAL INDEX KEY: 0001812025 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 24654267 MAIL ADDRESS: STREET 1: C/O DYNAVAX TECHNOLOGIES CORPORATION STREET 2: 2100 POWELL STREET, SUITE 1900 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-02-15 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001812025 Burgess Justin C/O DYNAVAX TECHNOLOGIES 2100 POWELL STREET, SUITE 720 EMERYVILLE CA 94608 0 1 0 0 Chief Accounting Officer 0 Common Stock 2024-02-16 4 M 0 6667 A 15803 D Common Stock 2024-02-16 4 F 0 2378 12.41 D 13425 D Restricted Stock Unit 2024-02-16 4 M 0 6667 D Common Stock 6667 13333 D Stock Options (Right to Buy) 12.48 2024-02-15 4 A 0 13500 0.00 A 2031-02-15 Common Stock 13500 13500 D Restricted Stock Unit 2024-02-15 4 A 0 21900 A Common Stock 21900 21900 D Code M: Exercise or conversion of derivative security Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 16, 2023. Code F: Payment of exercise price or tax liability by delivering or withholding securities Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units. Code A: Grant, award or other acquisition This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 15, 2024, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024. /s/ JUSTIN BURGESS 2024-02-20